Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial (Q38443071)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 October 2013
edit
Language Label Description Also known as
English
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial
scientific article published on 11 October 2013

    Statements

    Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial (English)
    Peter Tsang
    Cynthia B Strout
    Malcolm Sperling
    David P Greenberg
    Ayca Ozol-Godfrey
    Carlos DiazGranados
    Victoria Landolfi
    11 October 2013
    2507-2517

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit